Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare M Isacke

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|January 4, 2021
The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgeryGerald Gui, Effrosyni Panopoulou, Sarah Tang, et al.
European Journal of Immunology|May 1, 2010
The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansionSiân Lax, Debbie L Hardie, Amy Wilson, et al.
Breast Cancer Research and Treatment|April 8, 2009
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplificationPamela Klingbeil, Rachael Natrajan, Gemma Everitt, et al.
Cellular Immunology|September 21, 2005
Report on antibodies submitted to the stromal cell section of HLDA8Christopher D Buckley, Sapna Halder, Debbie Hardie, et al.
Molecular Cancer Therapeutics|November 18, 2022
Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of SarcomaRachel J Evans, Douglas W Perkins, Joanna Selfe, et al.
Science Signaling|February 11, 2016
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migrationMarie Locard-Paulet, Lindsay Lim, Giulia Veluscek, et al.
Cancer Research|May 8, 2013
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitorsAndrea Morandi, Lesley-Ann Martin, Qiong Gao, et al.
FEBS Letters|July 14, 2007
CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repairSiân Lax, Tie Zheng Hou, Eric Jenkinson, et al.
Nature Communications|June 11, 2021
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasisUte Jungwirth, Antoinette van Weverwijk, Rachel J Evans, et al.
Nature Communications|January 19, 2016
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessAlexandra Avgustinova, Marjan Iravani, David Robertson, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|January 4, 2021
The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgeryGerald Gui, Effrosyni Panopoulou, Sarah Tang, et al.
European Journal of Immunology|May 1, 2010
The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansionSiân Lax, Debbie L Hardie, Amy Wilson, et al.
Breast Cancer Research and Treatment|April 8, 2009
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplificationPamela Klingbeil, Rachael Natrajan, Gemma Everitt, et al.
Cellular Immunology|September 21, 2005
Report on antibodies submitted to the stromal cell section of HLDA8Christopher D Buckley, Sapna Halder, Debbie Hardie, et al.
Molecular Cancer Therapeutics|November 18, 2022
Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of SarcomaRachel J Evans, Douglas W Perkins, Joanna Selfe, et al.
Science Signaling|February 11, 2016
Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migrationMarie Locard-Paulet, Lindsay Lim, Giulia Veluscek, et al.
Cancer Research|May 8, 2013
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitorsAndrea Morandi, Lesley-Ann Martin, Qiong Gao, et al.
FEBS Letters|July 14, 2007
CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repairSiân Lax, Tie Zheng Hou, Eric Jenkinson, et al.
Nature Communications|June 11, 2021
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasisUte Jungwirth, Antoinette van Weverwijk, Rachel J Evans, et al.
Nature Communications|January 19, 2016
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessAlexandra Avgustinova, Marjan Iravani, David Robertson, et al.
Pageof 10